- Home
- Publications
- Publication Search
- Publication Details
Title
Sunitinib in solid tumors
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 18, Issue 6, Pages 821-834
Publisher
Informa Healthcare
Online
2009-05-20
DOI
10.1517/13543780902980171
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma
- (2017) P. Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of the efficacy and safety of sunitinib in treatment-naïve and pretreated Japanese patients (pts) with metastatic renal cell carcinoma (mRCC)
- (2017) H. Uemura et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
- (2017) R. M. Witteles et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of sunitinib malate (SM) in subjects with metastatic and/or surgically unresectable non-GIST soft tissue sarcomas
- (2017) C. E. Vigil et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I study to evaluate the safety and efficacy of sunitinib in combination with FOLFIRI in treatment-naïve metastatic colorectal cancer (mCRC)
- (2017) N. Starling et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib (SU) in combination with pemetrexed (P) in patients (pts) with advanced solid malignancies: A phase I dose escalation study
- (2017) L. Q. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential administration of sunitinib (SU) and docetaxel (D) in women with advanced breast cancer (ABC): an exploratory evaluation
- (2017) G. Mariani et al. JOURNAL OF CLINICAL ONCOLOGY
- Final results of a phase II study of sunitinib in patients (pts) with relapsed or refractory urothelial carcinoma (UC)
- (2017) D. J. Gallagher et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial of Sunitinib Malate plus Interferon-α for Patients with Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. Clinical Genitourinary Cancer
- Retrospective Analysis of the Safety and Efficacy of Interleukin-2 After Prior VEGF-targeted Therapy in Patients With Advanced Renal Cell Carcinoma
- (2009) Daniel C. Cho et al. JOURNAL OF IMMUNOTHERAPY
- Pharmacokinetics of sunitinib in hemodialysis
- (2008) H. Izzedine et al. ANNALS OF ONCOLOGY
- Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib
- (2008) M. E. Lacouture et al. ANNALS OF ONCOLOGY
- Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
- (2008) A A M van der Veldt et al. BRITISH JOURNAL OF CANCER
- The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation
- (2008) P Wolter et al. BRITISH JOURNAL OF CANCER
- Sequential therapy with sorafenib and sunitinib in renal cell carcinoma
- (2008) Arkadiusz Z. Dudek et al. CANCER
- Heart failure associated with sunitinib malate
- (2008) Aarif Y. Khakoo et al. CANCER
- Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis
- (2008) Christian Eichelberg et al. EUROPEAN UROLOGY
- Immunotherapy for renal cell cancer in the era of targeted therapy
- (2008) Chris Coppin Expert Review of Anticancer Therapy
- Rationale and Evidence for Sunitinib in the Treatment of Malignant Paraganglioma/Pheochromocytoma
- (2008) Anthony M. Joshua et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011
- (2008) John A. Olson et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib Versus Hormone Therapy in Patients With Advanced Renal Cell Carcinoma: A Randomized Phase III Clinical Trial
- (2008) Alain Ravaud et al. JOURNAL OF CLINICAL ONCOLOGY
- Allogeneic Hematopoietic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia With 17p Deletion: A Retrospective European Group for Blood and Marrow Transplantation Analysis
- (2008) Johannes Schetelig et al. JOURNAL OF CLINICAL ONCOLOGY
- Documentation of Thyroid Function in Clinical Studies With Sunitinib: Why Does It Matter?
- (2008) David H. Garfield et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer Survivors and Hot Flashes: The Search for Nonhormonal Treatments
- (2008) Nancy E. Avis JOURNAL OF CLINICAL ONCOLOGY
- Treatment Considerations for Gallbladder Cancer Should Include Extent of Surgery
- (2008) Sean P. Cleary et al. JOURNAL OF CLINICAL ONCOLOGY
- In Reply
- (2008) Amy C. Degnim et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Gestational Choriocarcinoma Mimicking a Uterine Adenocarcinoma
- (2008) Darren K. Patten et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer
- (2008) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2008) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
- (2008) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor
- (2008) Michael C. Heinrich et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient With Malignant Paraganglioma Responding to the Multikinase Inhibitor Sunitinib Malate
- (2008) Noah M. Hahn et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336
- (2008) Alvaro Moreno-Aspitia et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology
- (2008) Eric Winer et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib
- (2008) S. E. Rosenbaum et al. SUPPORTIVE CARE IN CANCER
- Sunitinib in the management of gastrointestinal stromal tumours (GISTs)
- (2007) T.G. Hopkins et al. EJSO
- Efficacy of Sunitinib and Sorafenib in Metastatic Papillary and Chromophobe Renal Cell Carcinoma
- (2007) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma and various other solid tumors
- (2007) Aristidis Polyzos JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Antitumor Effects of Sunitinib or Sorafenib in Patients With Metastatic Renal Cell Carcinoma Who Received Prior Antiangiogenic Therapy
- (2007) Ila Tamaskar et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started